Operating Lease, Right-of-Use Asset of Matinas BioPharma Holdings, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Matinas BioPharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Matinas BioPharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,351,000, a 48% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Matinas BioPharma Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,351,000 -$1,267,000 -48% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,462,000 -$1,308,000 -47% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,571,000 -$1,348,000 -46% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,680,000 -$1,384,000 -45% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $2,618,000 -$588,000 -18% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $2,770,000 -$575,000 -17% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $2,919,000 -$561,000 -16% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $3,064,000 -$549,000 -15% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $3,206,000 -$536,019 -14% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $3,345,000 -$599,158 -15% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,480,000 -$602,763 -15% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $3,613,000 -$606,000 -14% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $3,742,019 -$610,569 -14% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $3,944,158 +$910,003 +30% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $4,082,763 +$933,019 +30% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $4,219,000 +$942,361 +29% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $4,352,588 +$951,452 +28% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $3,034,155 -$489,143 -14% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $3,149,744 -$493,554 -14% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $3,276,639 -$484,568 -13% 31 Dec 2020 10-K/A 11 Mar 2022 2021 FY
Q3 2020 $3,401,136 -$475,933 -12% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $3,523,298 -$467,643 -12% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $3,643,298 -$459,687 -11% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $3,761,207 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q3 2019 $3,877,069 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $3,990,941 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $4,102,985 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.